Since its founding 20 years ago Alnylam has led the RNAi Revolution and continues101723 633 AM Alnylam Pharmaceuticals Press Release  Aug 03 2022  Alnylam Reports Positive Topline Results from APOLLOB Phase 3 Study of Patisira httpsinvestorsalnylamcompressreleaseid26851 79to deliver on a bold vision to turn scientific possibility into reality